TECX Insider Trading
Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $18,767,941.54
Insider Selling (Last 12 Months): $0.00
Tectonic Therapeutic Insider Trading History Chart
This chart shows the insider buying and selling history at Tectonic Therapeutic by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Tectonic Therapeutic Share Price & Price History
Current Price: $23.51
Price Change: ▼ Price Decrease of -1.11 (-4.51%)
As of 03/13/2025 05:00 PM ET
Tectonic Therapeutic Insider Trading History
Tectonic Therapeutic Institutional Trading History
Data available starting January 2016
Tectonic Therapeutic, Inc. engages in discovery and development of therapeutic proteins & antibodies. The company was founded by Timothy A. Springer and Andrew Kruse in 2019 and is headquartered in Watertown, MA.
Read More on Tectonic Therapeutic
Today's Range
Now: $23.51
52 Week Range
Now: $23.51
Volume
84,010 shs
Average Volume
375,152 shs
Market Capitalization
$346.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.71
Who are the company insiders with the largest holdings of Tectonic Therapeutic?
Who are the major institutional investors of Tectonic Therapeutic?
Which institutional investors are selling Tectonic Therapeutic stock?
In the previous quarter, TECX stock was sold by these institutional investors:
- Atlas Venture Life Science Advisors LLC
- Vanguard Group Inc.
- ADAR1 Capital Management LLC
- 5AM Venture Management LLC
- Boothbay Fund Management LLC
- Renaissance Technologies LLC
- Bridgeway Capital Management LLC
- Wells Fargo & Company MN
Which institutional investors are buying Tectonic Therapeutic stock?
During the last quarter, TECX stock was purchased by institutional investors including:
- Paradigm Biocapital Advisors LP
- Farallon Capital Management LLC
- Invesco Ltd.
- Susquehanna International Group LLP
- Balyasny Asset Management L.P.
- Woodline Partners LP
- Soleus Capital Management L.P.
- Jane Street Group LLC
During the previous year, these company insiders have bought Tectonic Therapeutic stock:
- Timothy A Springer (Director)
- Daniel Lochner (CFO)
Learn More investors buying Tectonic Therapeutic stock.